Remote adapted physical activity program to improve life for adults with IBD
Official title: Pilot Feasibility and Impact Study of a Remote Adapted Physical Activity Program on the Quality of Life of Patients With Inflammatory Bowel Disease (IBD)
Run by Raincy Montfermeil Hospital Group · NCT07191106 · Data updated 2026-11-12
This pilot will test whether a home-delivered adapted physical activity program can improve quality of life for adults with Crohn's disease or ulcerative colitis.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 72 (estimated) |
| Sponsor | Raincy Montfermeil Hospital Group Research network |
| Locations | 2 sites (Montfermeil and 1 other locations) |
| Status | Recruiting |
| Started | September 15, 2025 |
| Main results expected | October 30, 2025 |
| Study ends | March 31, 2026 |
| Registry record updated | September 24, 2025 |
| Trial ID | NCT07191106 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults (18+) with a confirmed IBD diagnosis for at least six months who are motivated, medically cleared for exercise, have internet access and a compatible device, and are not already highly physically active.
✕Probably not a fit
Patients with medical contraindications to exercise, significant psychological disorders that prevent participation, those already engaging in very high levels of physical activity, or those without internet/device access are unlikely to benefit from this program.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This pilot interventional program delivers an adapted physical activity (APA) regimen remotely using the MOOV+ application to adults with inflammatory bowel disease. Participants must be at least 18, have a confirmed IBD diagnosis for six months or more, medical clearance for exercise, and internet access; highly physically active individuals are excluded. The program is designed to provide light-to-moderate tailored exercise sessions with remote monitoring and guidance and will measure changes in quality of life and feasibility outcomes. The trial is conducted at GHI Le Raincy Montfermeil and CHU Nantes, with collaboration from Janssen Cilag S.A.S.
Why it matters
Potential benefit: If successful, the program could improve patients' quality of life, reduce fatigue, and make tailored exercise easier to access for people with IBD.
How similar studies have gone: Previous small studies and exercise programs in IBD have shown promise for symptom and quality-of-life improvements, but remotely delivered adapted physical activity programs remain relatively novel and less well tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults aged 18 years and older * Diagnosis of Inflammatory Bowel Disease (IBD) established for at least 6 months * Patient is motivated to participate in the Adapted Physical Activity (APA) program * Medical certificate confirming fitness to engage in remote physical activity * Access to a digital device with internet connectivity enabling use of the MOOV+ application at home * Written informed consent freely given after appropriate information * Affiliation with, or beneficiary of, a national health insurance system Exclusion Criteria: * Patients under 18 years of age * Medical contraindication to physical activity * High levels of physical activity as defined by the International Physical Activity Questionnaire (IPAQ): * Total \>1500 MET-min/week of vigorous activity on at least 3 days, OR * Total physical activity \>3000 MET-min/week, regardless of distribution * Presence of psychological disorders that may interfere with study participation * Lack of access to a device or internet connection enabling remote participation * Pregnant or breastfeeding women * Patients under legal guardianship or curatorship * Patients under legal protection
Where it's running
-
GHI Le Raincy Montfermeil
Montfermeil, France Recruiting -
CHU Nantes
Nantes, France Not yet recruiting
Study contacts
- Study coordinator: Stephane NAHON, Professor
- Email: stephane.nahon@ght-gpne.fr
- Phone: +33141708000
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
DISC-0974-201 for adults with IBD-related anemia
This Phase 2 trial will test whether DISC-0974-201 helps adults with inflammatory bowel disease who have anemia driven by inflammation.
-
Familial IBD Early Risk
This study tests whether clinical, environmental, and immune factors in first-degree relatives of people with Crohn’s disease or ulcerative colitis can predict who will develop IBD.
-
Moderate breathing and movement: Can regular exercise help people with quiescent inflammatory bowel disease feel better?
This trial tests whether a moderate-intensity exercise program improves quality of life for adults with Crohn's disease or ulcerative colitis who are currently in clinical remission.
-
Mediterranean Diet and Time-Restricted Feeding in Ulcerative Colitis in Remission
This study tests whether a Mediterranean diet, with or without an 8-hour eating window, helps gut health and quality of life in adults with ulcerative colitis in remission.
-
Screening for lipid disorders in children and teens with chronic diseases to flag cardiovascular risk
This study tests a blood test and a questionnaire to screen children and teens with chronic conditions for lipid metabolism disorders and familial hyperlipidemia.
-
Wearable data to spot IBD flareups in people with ulcerative colitis or Crohn's disease
This study tests whether heart‑rate variability from participants’ own wearables can help predict IBD flares.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.